Synthetic Anti-Infective Drugs CAS 192725 -17-0 Lopinavir

China Synthetic Anti-Infective Drugs CAS 192725-17-0 Lopinavir, Find details about China Lopinavir, Lopinavir Powder from Synthetic Anti-Infective Drugs CAS 192725-17-0 Lopinavir

Model NO.
HNB-280
Trademark
HNB-Biotech
Transport Package
Aluminium Foil Bag, Cardboard Drum
Origin
Shaanxi, China
Model NO.
HNB-280
Trademark
HNB-Biotech
Transport Package
Aluminium Foil Bag, Cardboard Drum
Origin
Shaanxi, China
Synthetic anti-infective drugs CAS 192725-17-0 Lopinavir
Synthetic Anti-Infective Drugs CAS 192725-17-0 Lopinavir

Synthetic Anti-Infective Drugs CAS 192725-17-0 Lopinavir
Product nameLopinavir
Cas No.192725-17-0
Molecular FormulaC37H48N4O5
AppearanceWhite powder

Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM.Target: HIV proteaseLopinavir is a potent inhibitor of Rh123 efflux in Caco-2 monolayers with IC50 of 1.7 mM. Lopinavir exposure (72 hours) in LS 180V cells reduces the content of intracellular Rh123. Lopinavir induces P-glycoprotein immunoreactive protein and messenger RNA levels in LS 180V cells. Lopinavir inhibits subtype C clone C6 with IC50 of 9.4 nM. Lopinavir inhibits CYP3A with IC50 of 7.3 mM in human liver microsomes, while produces negligible or weak inhibition of human CYP1A2, 2B6, 2C9, 2C19 and 2D6. Lopinavir (10 mg/kg, orally) results in Cmax of 0.8 μg/mL and oral bioavailability of 25% in rats.Synthetic Anti-Infective Drugs CAS 192725-17-0 LopinavirSynthetic Anti-Infective Drugs CAS 192725-17-0 LopinavirSynthetic Anti-Infective Drugs CAS 192725-17-0 LopinavirSynthetic Anti-Infective Drugs CAS 192725-17-0 LopinavirSynthetic Anti-Infective Drugs CAS 192725-17-0 LopinavirSynthetic Anti-Infective Drugs CAS 192725-17-0 LopinavirSynthetic Anti-Infective Drugs CAS 192725-17-0 Lopinavir
Synthetic Anti-Infective Drugs CAS 192725-17-0 Lopinavir